Regulating lactate levels in triple negative breast cancer presents a promising avenue for therapeutic intervention

被引：0
|
作者：
Prasad, Chandra Prakash
Umar, Sheikh Mohammad
Dev, Arundhathi J. R.
Kashyap, Akanksha
Rathee, Meetu
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3074
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Ceritinib is a novel triple negative breast cancer therapeutic agent
    Shengli Dong
    Hassan Yousefi
    Isabella Van Savage
    Samuel C. Okpechi
    Maryl K. Wright
    Margarite D. Matossian
    Bridgette M. Collins-Burow
    Matthew E. Burow
    Suresh K. Alahari
    Molecular Cancer, 21
  • [42] Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer
    Sai, Boya Manasa
    Dinakar, Yirivinti Hayagreeva
    Kumar, Hitesh
    Jain, Rupshee
    Kesharwani, Sharyu
    Kesharwani, Siddharth S.
    Mudavath, Shyam lal
    Ramkishan, Ajmeer
    Jain, Vikas
    THERAPEUTIC DELIVERY, 2024, 15 (11) : 871 - 891
  • [43] Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
    Naik, Adviti
    Decock, Julie
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] CUL4A, a Promising New Therapeutic Target for Triple Negative (Basal-Like) Breast Cancer Patients
    Shin, S. J.
    Lee, L.
    Chadwick, P.
    Liu, Y. F.
    Monni, S.
    Zhou, P.
    LABORATORY INVESTIGATION, 2011, 91 : 63A - 63A
  • [45] CUL4A, a Promising New Therapeutic Target for Triple Negative (Basal-Like) Breast Cancer Patients
    Shin, S. J.
    Lee, L.
    Chadwick, P.
    Liu, Y. F.
    Monni, S.
    Zhou, P.
    MODERN PATHOLOGY, 2011, 24 : 63A - 63A
  • [46] Proteolysis Targeting Chimera (PROTAC) as a promising novel therapeutic modality for the treatment of triple-negative breast cancer (TNBC)
    Dogheim, Gaidaa M.
    Amralla, Mohamed T.
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (04) : 629 - 653
  • [47] Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer
    Azari, Mandana
    Bahreini, Farbod
    Uversky, Vladimir N.
    Rezaei, Nima
    BIOCHEMICAL PHARMACOLOGY, 2023, 210
  • [48] Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
    Sofianidi, Amalia
    Dumbrava, Ecaterina E.
    Syrigos, Konstantinos N.
    Nasrazadani, Azadeh
    CANCERS, 2024, 16 (06)
  • [49] Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy
    Bhise, Ketki
    Gavande, Navnath S.
    Iyer, Arun K.
    DRUG DISCOVERY TODAY, 2023, 28 (11)
  • [50] ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer
    Tu, Xinyi
    Kahila, Mohamed M.
    Zhou, Qin
    Yu, Jia
    Kalari, Krishna R.
    Wang, Liewei
    Harmsen, William S.
    Yuan, Jian
    Boughey, Judy C.
    Goetz, Matthew P.
    Sarkaria, Jann N.
    Lou, Zhenkun
    Mutter, Robert W.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (11) : 2462 - 2472
12345